Plasma total fatty acids at baseline and after 24 mo of intervention were analyzed by gas chromatography coupled to mass spectrometry (GC-MS), using non-fasting plasma samples.
Online Supplemental Material using silanized glass vials. A volume of 750 μL methanolic-HCl (3N) was added, and the sample vortexed and incubated in a water bath at 95°C for 2 h. A calibration curve was constructed using a standard series containing 13 fatty acids in their free forms, processed as above. After cooling to room temperature, the samples were extracted with 250 μL hexane containing 2g/L butylated hydroxy toluene. The supernatants containing the fatty acid methyl esters were transferred to glass vials. An AS3000 autosampler (Thermo Scientific, Hemel Hempstead, United Kingdom) was used to introduce 1 μL sample, using split injection (1:20) and an inlet temperature of 220°C, into a Focus GC-DSQ II GC-MS system (Thermo Scientific, Hemel Hempstead, United Kingdom). The GC was equipped with a BPX70 column (25 m x 0.22 mm, 25 μm film, SGE, Weiterstadt, Germany). Helium was used as carrier gas at 1.3 mL/min. The column temperature was initially held at 150°C for 2 min, increased at 4°C/min to 180°C, followed by an increase of 2°C/min to 188°C. The temperature was finally increased to 220°C at 10°C/min. The total run time was 16.7 min.
The following settings were used: ion source temperature, 200°C; transfer line temperature, 250°C; and electron energy, -70 eV. Detection was achieved using selective ion monitoring (Supplemental Table 1 ). 17:0, liberated from TG-17:0, was used as an internal standard. The ratio between 21:0 and 17:0 was monitored to assess efficiency of the hydrolysis and derivatization reaction. Xcalibur software pack version 1.4 (Thermo Scientific, Hemel Hempstead, United Kingdom) was used for data processing.
Correlations of fatty acids with B-vitamin markers and brain atrophy rates
Correlation of omega-3 fatty acids with brain atrophy rates are found in the main results section of the paper. In addition to the omega-3 fatty acids, arachidonic acid (20:4n-6) and total fatty acid concentration showed significant negative correlations with brain atrophy rates (Supplemental Table 2 ). When analyzed in B-vitamin treated subjects only, palmiticOnline Supplemental Material (16:1n-7) and oleic acid (18:1n-9) were added to the list of fatty acids significantly inversely correlated with atrophy rates (Supplemental Table 2 ). No fatty acid was significantly correlated with brain atrophy rate in the placebo group.
Since the concentration of total fatty acids might explain some of the associations for the individual FA, we repeated the analysis using relative amounts of fatty acids (Supplemental Table 3 ). The relative proportions of combined omega-3 (r = −0.29, P = 0.012) and DHA (r = −0.33, P = 0.005), but not EPA (r = −0.21, P = 0.075), were significantly inversely associated with brain atrophy rates in the B-vitamin group. None of the additional fatty acids which showed significant correlations with the brain atrophy rate when analyzed by absolute concentrations, were significant when analyzed by relative concentrations, regardless of treatment group (Supplemental Table 3 ). education level, baseline diastolic blood pressure, and baseline plasma concentrations of triglycerides (log), creatinine, and total homocysteine (log). All fatty acid concentrations were transformed using the natural log prior to analyses. *P ˂ 0.05 (two-tailed). N=168 (All),
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